Table 1.
Reported thresholds (in kilopascals) for staging of liver fibrosis with MR elastography.
| Population and Study | N | Fibrosis Stage | |||
|---|---|---|---|---|---|
| ≥F1 | ≥F2 | ≥F3 | F4 | ||
| Chronic liver disease and healthy volunteers | |||||
| Choi et al, 2013. Invest Radiol. 48: 607–613. | 168 | 2.9 | 3.0 | 3.4 | 4.00 |
| Ichikawa et al, 2015. J Magn Reson Imaging. 42: 204–210. | 129 | 2.60 | 2.80 | 3.60 | 4.00 |
| Yoshimitsu et al, 2016. Eur Radiol. 26: 656–663. | 70 | 3.13 | 3.85 | 4.28 | 5.38 |
| Morisaka et al, 2018. J Magn Reson Imaging. 47: 12681275. | 80 | 2.32 | 2.61 | 3.02 | 4.23 |
| Chronic hepatitis B or C | |||||
| Venkatesh et al, 2014. Eur Radiol. 24(1): 70–78. | 63 | 2.74 | 3.2 | 3.7 | 4.33 |
| Chang et al, 2016. Radiology. 280: 88–97. | 352 | 2.56 | 2.57 | 2.92 | 3.67 |
| Shi et al, 2016. Am J Gastroenterol. 111: 823–833. | 179 | 3.08 | 3.13 | 3.74 | 4.18 |
| Loomba et al, 2014. Hepatology. 60: 1920–1928. | 117 | 3.02 | 3.58 | 3.64 | 4.67 |
| Fatty liver disease | |||||
| Chen et al, 2017. Radiology. 283: 418–428. | 111 | 2.60 | 3.50 | 3.60 | 4.52 |
| Imajo et al, 2016. Gastroenterology. 150: 626–637. | 142 | 2.50 | 3.40 | 4.80 | 6.70 |
| Park et al, 2017. Gastroenterology. 152: 598–607. | 104 | 2.65 | 2.86 | 2.99 | 3.35 |
| Imajo et al, 2022. Clin Gastroent and Hepatol. 20: 908–917. | 231 | 2.92 | 3.19 | 3.90 | 4.62 |